Efficacy and safety of Dengzhan Shengmai capsule in the treatment of chronic heart failure: a systematic review and meta-analysis
BackgroundDengzhan Shengmai Capsule (DZSMC) is a potential treatment for chronic heart failure (CHF). However, its specific benefits in the treatment of CHF remain unclear.MethodsRelated randomized controlled trials were searched in eight databases up to January 28, 2025, and included studies were d...
Saved in:
| Main Authors: | Shenghua Lu, Yunfeng Yu, Sisi Dai, Yaqi Hu, Qin He, Rongzhen Liu, Jianhe Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1385061/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Underlying Mechanism of Jiuwei Shengmai Powder in Improving Myocardial Hypoxia at High Altitude Based on Network Pharmacology and Molecular Docking
by: Cong Wu, et al.
Published: (2025-06-01) -
Modified Huangqi Shengmai Yin enhances ruminal microbiome and metabolites activity in dairy cows with subclinical mastitis
by: Chenyibo Zhang, et al.
Published: (2025-08-01) -
The Shengmai San Exerts Therapeutic Effects on Type 2 Diabetes by Modulating the PI3K/AKT/GSK3B Signaling Pathway
by: Shang H, et al.
Published: (2025-04-01) -
The effect of Jintiange capsules on pain in patients with primary osteoporosis: a systematic review and meta-analysis
by: Wei Li, et al.
Published: (2025-05-01) -
Metabolomics reveals the mechanism of Zhilong Huoxue Tongyu capsule in the treatment of heart failure
by: Li Chen, et al.
Published: (2025-04-01)